Drug Database
Back to search

France· FR:69474926

KALETRA (80 mg + 20 mg)/ml, solution buvable

A lopinavir and ritonavir product containing lopinavir + ritonavir, registered in France by ABBVIE DEUTSCHLAND (ALLEMAGNE), on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC J05AR10

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedKALETRA (80 mg + 20 mg)/ml, solution …ATCJ05AR10REGISTER NO.FR:69474926PACKS LISTED2CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about lopinavir + ritonavirAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Lopinavir and ritonavir is registered in 15 of 19 countries.

Countries holding a registration under ATC J05AR10 (lopinavir and ritonavir), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 10 of them publish a price we can compare per daily dose
Search lopinavir and ritonavir products by name

Lopinavir and ritonavir · ATC J05AR10

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lopinavir and ritonavir costs, country by country.

Normalised to the WHO defined daily dose (0.8 g), the median price runs from $17.81 in Switzerland to $763.00 in France — a ×43 gap.

  • France: $763.00 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Lopinavir and ritonavir · price per daily dose (0.8 g)

USD · FX 28 Sept 2026

  • FR France$763.00
  • CH Switzerland$17.81
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
LOPINAVIR + RITONAVIR
Manufacturer
ABBVIE DEUTSCHLAND (ALLEMAGNE)
Country
France (FR)
ATC code
J05AR10
ATC class
Lopinavir and ritonavir
Defined daily dose
0.8 g, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

2 priced
  • cip13
    3400930117293
    2 flacon(s) multidose(s) jaune(brun) polytéréphtalate (PET) de 60 ml avec 2 seringue(s) pour administration orale 2ml
    EUR 175.23
  • cip13
    3400935668196
    5 flacon(s) multidose(s) jaune(brun) polytéréphtalate (PET) de 60 ml avec 5 seringue pour administration orale de 5 mL
    EUR 435.33

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

136 interactions on record for lopinavir and ritonavir.

Graded by severity as the source publishes them — 17 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check lopinavir and ritonavir against other medicinesHow interaction checks work

Lopinavir and ritonavir · interactions on record

136 records

  • 17 severe
  • 71 moderate
  • 7 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • DolasetronA04AA04severe
  • PapaverinC04AX38severe
  • RosuvastatinC10AA07severe

41 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lopinavir and ritonavir in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lopinavir and ritonavir products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Estonia · Lopinavir/Ritonavir Ranbaxy, Lopinavir/Ritonavir Sun
  • Spain · Lopinavir / Ritonavir Accord
  • United Kingdom (Northern Ireland) · Kaletra, Lopinavir / Ritonavir Accord
  • Iceland · Kaletra, Lopinavir/Ritonavir Mylan
  • Liechtenstein · Kaletra, Lopinavir/Ritonavir Viatris
  • Lithuania · Lopinavir / Ritonavir Sun, Lopinavir /Ritonavir Ranbaxy
  • Latvia · Lopinavir/ Ritonavir Ranbaxy, Lopinavir/ Ritonavir Sun
  • Netherlands · Lopinavir/Ritonavir Accord
  • Norway · Kaletra, Lopinavir/Ritonavir Viatris
  • Portugal · Lopinavir + Ritonavir Farmoz
  • Slovenia · Lopinavir/Ritonavir Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e7843202-12d2-4ebf-8eb8-0c1d903dc41e
GET /v1/drugs/e7843202-12d2-4ebf-8eb8-0c1d903dc41e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "69474926",
  "date_amm": "2001-03-20",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/01/172",
  "substance": "LOPINAVIR + RITONAVIR",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution buvable",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about lopinavir and ritonavir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console